Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Female Subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Betahistine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors OBEcure
- 08 May 2009 Planned number of patients changed from 180 to 187 as reported by ClinicalTrials.gov.
- 20 Jan 2009 Status changed from recruiting to active, no longer recruiting, according to an Obecure media release. Results are expected by the end of Q2 2009.
- 15 Sep 2008 New trial record.